BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30382763)

  • 21. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
    Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
    J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-Elemene inhibits proliferation through crosstalk between glia maturation factor β and extracellular signal‑regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells.
    Zhu TZ; Li XM; Luo LH; Xu YH; Cao P; Liu Y; Liang GB
    Mol Med Rep; 2014 Aug; 10(2):1122-8. PubMed ID: 24866280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2.
    Liu SM; Lu J; Lee HC; Chung FH; Ma N
    Oncotarget; 2014 Oct; 5(19):9444-59. PubMed ID: 25275294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor induces c-fos and c-jun mRNA via Raf-1/MEK1/ERK-dependent and -independent pathways in bovine luteal cells.
    Chen DB; Davis JS
    Mol Cell Endocrinol; 2003 Feb; 200(1-2):141-54. PubMed ID: 12644307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RKIP regulates MAP kinase signaling in cells with defective B-Raf activity.
    Zeng L; Ehrenreiter K; Menon J; Menard R; Kern F; Nakazawa Y; Bevilacqua E; Imamoto A; Baccarini M; Rosner MR
    Cell Signal; 2013 May; 25(5):1156-65. PubMed ID: 23416466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.
    Golding SE; Rosenberg E; Neill S; Dent P; Povirk LF; Valerie K
    Cancer Res; 2007 Feb; 67(3):1046-53. PubMed ID: 17283137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-574-3p inhibits proliferation and invasion in esophageal cancer by targeting FAM3C and MAPK1.
    Jin LL; Zhang SJ; Lu GX; Lv F; Shang R; Yang J
    Kaohsiung J Med Sci; 2020 May; 36(5):318-327. PubMed ID: 31880039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation.
    Ghousein A; Mosca N; Cartier F; Charpentier J; Dupuy JW; Raymond AA; Bioulac-Sage P; Grosset CF
    Liver Int; 2020 Jan; 40(1):240-251. PubMed ID: 31612616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma.
    Chen L; Wang Q; Wang GD; Wang HS; Huang Y; Liu XM; Cai XH
    FEBS Lett; 2013 May; 587(9):1366-72. PubMed ID: 23507142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. USP10 promotes proliferation and migration and inhibits apoptosis of endometrial stromal cells in endometriosis through activating the Raf-1/MEK/ERK pathway.
    Chen Q; Hang Y; Zhang T; Tan L; Li S; Jin Y
    Am J Physiol Cell Physiol; 2018 Dec; 315(6):C863-C872. PubMed ID: 30281322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigallocatechin-3-gallate inhibits proliferation of human aortic smooth muscle cells via up-regulating expression of mitofusin 2.
    Shu Z; Yu M; Zeng G; Zhang X; Wu L; Tan X
    Eur J Cell Biol; 2014 Apr; 93(4):137-44. PubMed ID: 24880525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration.
    Rajalingam K; Wunder C; Brinkmann V; Churin Y; Hekman M; Sievers C; Rapp UR; Rudel T
    Nat Cell Biol; 2005 Aug; 7(8):837-43. PubMed ID: 16041367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway.
    Liu F; Zheng S; Liu T; Liu Q; Liang M; Li X; Sheyhidin I; Lu X; Liu W
    Mol Cell Biochem; 2013 Sep; 381(1-2):115-25. PubMed ID: 23709326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metastatic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways.
    Dou Z; Gao L; Ren W; Zhang H; Wang X; Li S; Zheng J; Kong X; Chi P; Zhi K
    Exp Cell Res; 2020 Nov; 396(2):112290. PubMed ID: 32956704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. microRNA-374 inhibits proliferation and promotes apoptosis of mouse melanoma cells by inactivating the Wnt signalling pathway through its effect on tyrosinase.
    Li XJ; Li ZF; Xu YY; Han Z; Liu ZJ
    J Cell Mol Med; 2019 Aug; 23(8):4991-5005. PubMed ID: 31207106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis.
    Wu J; Wong WW; Khosravi F; Minden MD; Penn LZ
    Cancer Res; 2004 Sep; 64(18):6461-8. PubMed ID: 15374955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-338 inhibits proliferation, migration, and invasion of gastric cancer cells by the Wnt/β-catenin signaling pathway.
    Song B; Lin HX; Dong LL; Ma JJ; Jiang ZG
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1290-1296. PubMed ID: 29565486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W
    Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.